ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

Nominations Sought for Disney-ACS Research Professor

November 19, 1993

ONS Accredited As Approver, Provider Of Continuing Education

April 22, 1988

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

Heidelberger Wins $100,000 Award

September 17, 1982

No Cancer Letter for Two Weeks

August 13, 1993